No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Express News | Avenue Therapeutics Inc Files for Mixed Shelf of Upto $35 Mln - SEC Filing
12 Health Care Stocks Moving In Monday's Pre-Market Session
Express News | Avenue Therapeutics Inc - Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Maxim Group Maintains Avenue Therapeutics(ATXI.US) With Buy Rating
Maxim Group Remains a Buy on Avenue Therapeutics (ATXI)
Avenue Therapeutics Q3 EPS $(1.92) Misses $(0.94) Estimate
No Data